The clinical syndrome of COVID-19 infection is complex and implies multiorgan involvement. It has become evident that neurological manifestations of COVID-19 are not rare and can involve both the central and peripheral nervous system. In a patient with confirmed or suspected COVID-19 infection, any acute neurologic symptoms, especially cerebrovascular related, should be considered a potential COVID-19 neurological complication. Reported cerebrovascular events in patients with COVID-19 are mainly ischemic, but also hemorrhagic strokes and cerebral venous thrombosis, especially in critically ill patients, have been described. To date, it is still not clear whether cerebrovascular manifestations are caused by the direct viral action or an indirect action mediated by inflammatory hyperactivation. In this paper recently published in Frontiers in Neurology, the authors systematically reviewed cerebrovascular diseases in COVID-19 infection focusing on clinical and aetiological presentation of stroke in COVID-19 patients with the aim at increasing knowledge and improving care of this frequent neurological event.
Cerebrovascular diseases in COVID-19 infection: The state of the art
You may also like
Presence of SARS-CoV-2 transcripts in the choroid plexus of MS and non-MS patients with COVID-19
March 3, 2021
